Integra LifeSciences Holdings Cor.../ US4579852082 /
| 2024-05-03 10:00:00 PM | Chg. +0.1400 | Volume | Bid12:55:16 AM | Ask12:55:16 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 28.8900USD | +0.49% | 1.47 mill. Turnover: 30.25 mill. |
29.1000Bid Size: 1,300 | 41.8500Ask Size: 100 | 2.26 bill.USD | - | 33.99 |
Assets
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 269.2510 | 300.1120 | 337.4040 | 287.5290 | 311.7030 | ||||||
| Intangible Assets | 1,159.6270 | 1,079.4960 | 1,031.5910 | 989.4360 | 1,145.5730 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 2,389.1110 | 2,332.8050 | 2,445.0720 | 2,377.9340 | 2,628.6670 | ||||||
| Inventories | 296.3320 | 280.3470 | 316.0540 | 310.1170 | 317.3860 | ||||||
| Accounts Receivable | 251.7990 | 265.7370 | 275.2960 | 225.5320 | 231.8310 | ||||||
| Cash and Cash Equivalents | 174.9350 | 138.8380 | 198.9110 | 470.1660 | 513.4480 | ||||||
| Current Assets | 822.1460 | 775.0820 | 858.1680 | 1,237.2020 | 1,153.7160 | ||||||
| Total Assets | 3,211.2570 | 3,107.8870 | 3,303.2400 | 3,615.1360 | 3,782.3830 | ||||||
Liabilities
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 93.9670 | 76.0500 | 113.0900 | 54.6080 | 61.8370 | ||||||
| Long-term debt | 1,781.1420 | 1,331.7130 | 1,303.0610 | 1,408.2210 | 1,501.1830 | ||||||
| Liabilities to Banks | 1,841.1000 | 1,354.2000 | 1,348.1000 | - | - | ||||||
| Provisions | 65.1000 | 57.8000 | 36.6000 | - | - | ||||||
| Liabilities | 2,248.9510 | 1,732.0910 | 1,886.5040 | 2,100.2690 | 2,097.5790 | ||||||
| Share Capital | .8130 | .8800 | .8870 | .8930 | .8960 | ||||||
| Total Equity | 962.3060 | 1,375.7960 | 1,416.7360 | 1,514.8670 | 1,684.8040 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 3,211.2570 | 3,107.8870 | 3,303.2400 | 3,615.1360 | 3,782.3830 | ||||||
Income Statement
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,188.2360 | 1,472.4410 | 1,517.5570 | 1,371.8680 | 1,542.4480 | ||||||
| Depreciation (total) | 88.9450 | 110.7300 | 109.4620 | 116.0310 | 119.8360 | ||||||
| Operating Result | 44.8040 | 110.9980 | 93.7600 | 151.3700 | 197.2300 | ||||||
| Interest Income | -34.7640 | -61.8830 | -43.1780 | -62.2840 | -43.6580 | ||||||
| Income Before Taxes | 11.3850 | 57.4030 | 60.1040 | 93.5200 | 214.6770 | ||||||
| Income Taxes | -53.3580 | -3.3980 | 9.9030 | -40.3720 | 45.6020 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 64.7430 | 60.8010 | 50.2010 | 133.8920 | 169.0750 | ||||||
Per Share
Cash Flow
| 2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 114.5440 | 199.6830 | 231.4330 | 203.8320 | 312.4270 | ||||||
| Cash Flow from Investing Activities | -1,221.3350 | -49.7050 | -162.6680 | -68.0730 | -161.4430 | ||||||
| Cash Flow from Financing | 1,168.9470 | -180.8720 | -8.7660 | 121.6250 | -98.2260 | ||||||
| Decrease / Increase in Cash | 72.8800 | -36.0970 | 60.0730 | 271.2550 | 43.2820 | ||||||
| Employees | 4,400 | 4,500 | 4,000 | - | - | ||||||
